[PLX] QoQ Quarter Result on 30-Jun-2021 [#Q2]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
16-Aug-2021
Financial Year
2021
Quarter
30-Jun-2021 [#Q2]
Profit Trend
QoQ- -105.32%
YoY- -170.87%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Revenue 16,085 8,549 12,054 6,427 11,320 19,495 10,790 30.52%
PBT -2,286 -6,667 -4,199 -11,241 -5,475 397 -4,437 -35.75%
Tax 416 908 96 128 2,207 -212 118 131.81%
NP -2,702 -6,667 -4,199 -11,241 -5,475 397 -4,437 -28.17%
Tax Rate - - - - - 53.40% - -
Total Cost 18,787 15,216 16,253 17,668 16,795 19,098 15,227 15.04%
Ratio Analysis
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
NP Margin -16.80 -77.99 -34.83 -174.90 -48.37 2.04 -41.12 -44.96%
Per Share
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
EPS -0.06 -0.15 -0.09 -0.25 -0.14 0.01 -0.14 -43.18%
EPS Diluted -0.06 -0.15 -0.09 -0.25 -0.14 0.01 -0.14 -43.18%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.